Company
Inogen, Inc.
Headquarters: Goleta, CA, United States
Employees: 1,021
CEO: Mr. Nabil Shabshab
Market Cap
$201.4 Million
USD as of July 1, 2025
Inogen, Inc. Categories
United States Healthcare Medical DevicesUnited States Healthcare United States Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $233.33 B |
| Boston Scientific Corporation | $154.34 B |
| Stryker | $151.06 B |
| Medtronic | $113.25 B |
| Edwards Lifesciences Corporation | $45.05 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Detailed Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Financials
| Last Financial Reports Date | Dec. 31, 2023 |
| Revenue TTM | $315.7 M |
| EBITDA | $-45,679,000 |
| Gross Profit TTM | $126.7 M |
| Profit Margin | -32.46% |
| Operating Margin | -28.63% |
| Quarterly Revenue Growth | -13.80% |
Stocks & Indices
Inogen, Inc. has the following listings and related stock indices.
Stock: NASDAQ: INGN wb_incandescent
Stock: FSX: 6IO wb_incandescent